Zheng Yang
Department of Metabolism and Pharmacokinetics
Bristol-Myers Squibb Research and Development
Wallingford
Connecticut 06492
USA
Name/email consistency: high
- Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties. Yang, Z., Zadjura, L.M., Marino, A.M., D'Arienzo, C.J., Malinowski, J., Gesenberg, C., Lin, P.F., Colonno, R.J., Wang, T., Kadow, J.F., Meanwell, N.A., Hansel, S.B. J. Pharm. Sci (2010)
- Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics. Yang, Z., Zadjura, L., D'Arienzo, C., Marino, A., Santone, K., Klunk, L., Greene, D., Lin, P.F., Colonno, R., Wang, T., Meanwell, N., Hansel, S. Biopharm. Drug. Dispos (2005)









